Skip to main content
. 2021 Sep 12;2021(9):CD011612. doi: 10.1002/14651858.CD011612.pub3

Comparison 21. N‐acetylcysteine versus Placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
21.1 Response rate 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.1.1 at 2 weeks 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.1.2 at 4 weeks 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.1.3 at 3 months 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.2 AE Back pain 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.3 AE Gastrointestinal problems 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.4 AE Joint pain 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.5 AE Muscle spasms 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.6 Remission rate 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.6.1 at 2 weeks 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.6.2 at 4 weeks 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.6.3 at 3 months 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.7 Depression rating scale score 1   Mean Difference (IV, Random, 95% CI) Totals not selected
21.7.1 at 2 weeks 1   Mean Difference (IV, Random, 95% CI) Totals not selected
21.7.2 at 4 weeks 1   Mean Difference (IV, Random, 95% CI) Totals not selected
21.7.3 at 3 months 1   Mean Difference (IV, Random, 95% CI) Totals not selected
21.8 Quality of life 1   Mean Difference (IV, Random, 95% CI) Totals not selected
21.8.1 at 3 months 1   Mean Difference (IV, Random, 95% CI) Totals not selected
21.9 Acceptability 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected
21.10 Acceptability ‐ adverse events 1   Odds Ratio (M‐H, Random, 95% CI) Totals not selected